Wells Fargo’s Oncolytics Biotech ONCY Stock Holding History

Wells Fargo’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.09K	Sell	6,413 -189	-3%	-$175	﹤0.01%	6188
2026 Q1	$5.6K	Buy	6,602 +1,201	+22%	+$1.19K	﹤0.01%	6093
2025 Q4	$4.72K	Buy	5,401 +1,000	+23%	+$1.08K	﹤0.01%	6110
2025 Q3	$6.16K	Hold	4,401	–	–	﹤0.01%	6038
2025 Q2	$3.4K	Hold	4,401	–	–	﹤0.01%	6143
2025 Q1	$2.42K	Hold	4,401	–	–	﹤0.01%	6131
2024 Q4	$4.02K	Hold	4,401	–	–	﹤0.01%	6098
2024 Q3	$3.83K	Hold	4,401	–	–	﹤0.01%	5964
2024 Q2	$4.36K	Hold	4,401	–	–	﹤0.01%	5895
2024 Q1	$4.67K	Sell	4,401 -263	-6%	-$294	﹤0.01%	5902
2023 Q4	$6.3K	Sell	4,664 -1,537	-25%	-$2.4K	﹤0.01%	5925
2023 Q3	$13.5K	Hold	6,201	–	–	﹤0.01%	5727
2023 Q2	$16.1K	Buy	6,201 +901	+17%	+$1.5K	﹤0.01%	5798
2023 Q1	$6.36K	Buy	5,300 +1,800	+51%	+$2.83K	﹤0.01%	5993
2022 Q4	$5.71K	Sell	3,500 -800	-19%	-$1.22K	﹤0.01%	5730
2022 Q3	$5K	Hold	4,300	–	–	﹤0.01%	5915
2022 Q2	$4K	Hold	4,300	–	–	﹤0.01%	6103
2022 Q1	$7K	Buy	4,300 +2,400	+126%	+$4.03K	﹤0.01%	6391
2021 Q4	$3K	Buy	1,900 +300	+19%	+$555	﹤0.01%	6811
2021 Q3	$3K	Hold	1,600	–	–	﹤0.01%	6497
2021 Q2	$4K	Buy	1,600 +100	+7%	+$306	﹤0.01%	6405
2021 Q1	$6K	Buy	1,500 +500	+50%	+$1.49K	﹤0.01%	6459
2020 Q4	$2K	Sell	1,000 -1,000	-50%	-$2.4K	﹤0.01%	6281
2020 Q3	$3K	Sell	2,000 -1,142	-36%	-$2.1K	﹤0.01%	6087
2020 Q2	$6K	Hold	3,142	–	–	﹤0.01%	5944
2020 Q1	$4K	Buy	3,142 +2,500	+389%	+$6.24K	﹤0.01%	5900
2019 Q4	$3K	Hold	642	–	–	﹤0.01%	6132
2019 Q3	$0	Hold	642	–	–	﹤0.01%	6603
2019 Q2	$1K	Hold	642	–	–	﹤0.01%	6267
2019 Q1	$1K	Hold	642	–	–	﹤0.01%	5948
2018 Q4	$1K	Hold	642	–	–	﹤0.01%	6290
2018 Q3	$2K	Hold	642	–	–	﹤0.01%	6235
2018 Q2	$4K	Buy	+642	New	+$3.95K	﹤0.01%	6112

Other funds holding ONCY

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Wells Fargo's ONCY Position: Q2 2026 in Review

Wells Fargo reduced its Oncolytics Biotech (ONCY) stake by 2.9% in Q2 2026, selling an estimated $175 and leaving 6,413 shares worth $6.09K. The position accounts for ﹤0.01% of the portfolio, ranked #6188.

Wells Fargo first reported a position in ONCY in Q2 2018 and has held it in 33 quarters since. The position peaked at $16.1K in Q2 2023. 76 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

Wells Fargo held 6,413 shares of Oncolytics Biotech worth $6.09K as of Q2 2026.
Wells Fargo sold 189 Oncolytics Biotech shares in Q2 2026, an estimated $175.
Oncolytics Biotech made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6188 holding.
Wells Fargo first reported a position in Oncolytics Biotech in Q2 2018 and has held it in 33 quarters since.
Wells Fargo's Oncolytics Biotech position peaked at $16.1K in Q2 2023.
76 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.